CD274 and neoplasm: The PD-1/PD-L1 axis plays a key role in host immune monitoring and tumor microenvironment regulation, and hence inhibiting this pathway may release immune-responsive molecules and generate a long-lasting antitumor response in combination with anticancer drugs35,36.